Active Ingredient: LEUPROLIDE ACETATE
Proprietary Name: LEUPROLIDE ACETATE FOR DEPOT SUSPENSION
Dosage Form; Route of Administration: FOR SUSPENSION; INTRAMUSCULAR
Strength: 22.5MG/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N205054
Product Number: 001
Approval Date: Aug 28, 2018
Applicant Holder Full Name: INVAGEN PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
